These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 26506117)

  • 1. Comparison of the Liaison® Calprotectin kit with a well established point of care test (Quantum Blue - Bühlmann-Alere®) in terms of analytical performances and ability to detect relapses amongst a Crohn population in follow-up.
    Delefortrie Q; Schatt P; Grimmelprez A; Gohy P; Deltour D; Collard G; Vankerkhoven P
    Clin Biochem; 2016 Feb; 49(3):268-73. PubMed ID: 26506117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing a New Flow Immune-Chromatography Fast Assay with a Random Access Semi-Automatic Chemiluminescent Immunoassay to Measure Fecal Calprotectin.
    Perets TT; Huta Y; Ashorov O; Seef A; Dickman R
    Ann Clin Lab Sci; 2023 Sep; 53(5):784-788. PubMed ID: 37945019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Accuracy of Fecal Calprotectin for the Detection of Small Bowel Crohn's Disease through Capsule Endoscopy: An Updated Meta-Analysis and Systematic Review.
    Jung ES; Lee SP; Kae SH; Kim JH; Kim HS; Jang HJ
    Gut Liver; 2021 Sep; 15(5):732-741. PubMed ID: 33361549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Faecal calprotectin - the Crohn's disease activity predictor of the future.
    Ramphul P
    Clin Med (Lond); 2016 Jun; 16 Suppl 3(Suppl 3):s28. PubMed ID: 27252331
    [No Abstract]   [Full Text] [Related]  

  • 5. Noninvasive Assessment of Postoperative Disease Recurrence in Crohn's Disease: A Multicenter, Prospective Cohort Study on Behalf of the Italian Group for Inflammatory Bowel Disease.
    Furfaro F; D'Amico F; Zilli A; Craviotto V; Aratari A; Bezzio C; Spinelli A; Gilardi D; Radice S; Saibeni S; Papi C; Peyrin-Biroulet L; Danese S; Fiorino G; Allocca M
    Clin Gastroenterol Hepatol; 2023 Nov; 21(12):3143-3151. PubMed ID: 36521739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Head-to-head comparison of three stool calprotectin tests for home use.
    Haisma SM; Galaurchi A; Almahwzi S; Adekanmi Balogun JA; Muller Kobold AC; van Rheenen PF
    PLoS One; 2019; 14(4):e0214751. PubMed ID: 30998692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal Calprotectin Profiles in Crohn's Disease: A Longitudinal Data Analysis.
    Kawada T
    Clin Gastroenterol Hepatol; 2024 Aug; 22(8):1750-1751. PubMed ID: 38036280
    [No Abstract]   [Full Text] [Related]  

  • 8. [Calprotectin levels in meconium measured with an automated immunoassay (Liaison
    Oris C; Pons M; Rochette E; Tadrent M; Durif J; Pereira B; Justine P; Troin U; Gallot D; Bouvier D; Merlin É; Sapin V
    Ann Biol Clin (Paris); 2023 Oct; 81(4):388-394. PubMed ID: 37864444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring calprotectin in plasma and blood with a fully automated turbidimetric assay.
    Åsberg A; Løfblad L; Felic A; Hov GG
    Scand J Clin Lab Invest; 2019; 79(1-2):50-57. PubMed ID: 30761918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of fecal calprotectin extracts using the Diasorin
    Billet B; Choisnard L; Faure P; Guicherd D; Cussigh E; Peyrin E; Ravelet C; Chovelon B
    Clin Chem Lab Med; 2024 Jan; 62(1):e13-e15. PubMed ID: 37470268
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical Value of Detecting Fecal Calprotectin by Using Colloidal Gold Assay in Screening or Diagnosing Crohn's Disease.
    Zhang W; Fan Y; Chen M
    Gastroenterol Res Pract; 2023; 2023():8866828. PubMed ID: 38024527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sample comparison of BÜHLMANN fCAL Turbo and OC-FCa faecal calprotectin methods.
    O'Driscoll S; Piggott C; Benton SC
    Ann Clin Biochem; 2024 Aug; ():45632241273266. PubMed ID: 39093620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of DiaSorin Liaison
    de Paz Poves C; Barneo-Caragol C; Cillero Sánchez AI; Jimenez Mendiguchia L; Quirós Caso C; Moreno Rodríguez M; López González FJ; Prieto García MB
    Adv Lab Med; 2023 Dec; 4(4):419-424. PubMed ID: 38106502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Not Available].
    de Paz Poves C; Barneo-Caragol C; Cillero Sánchez AI; Jiménez Mendiguchia L; Quirós Caso C; Moreno Rodríguez M; López González FJ; Prieto García MB
    Adv Lab Med; 2023 Dec; 4(4):425-430. PubMed ID: 38106495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Faecal Calprotectin Assay by IDS: Validation and Comparison to DiaSorin Method.
    Castiglione V; Berodes M; Lukas P; Louis E; Cavalier E; Lutteri L
    Diagnostics (Basel); 2022 Sep; 12(10):. PubMed ID: 36292026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Point-of-care Intestinal Ultrasound in IBD Patients: Disease Management and Diagnostic Yield in a Real-world Cohort and Proposal of a Point-of-care Algorithm.
    Bots S; De Voogd F; De Jong M; Ligtvoet V; Löwenberg M; Duijvestein M; Ponsioen CY; D'Haens G; Gecse KB
    J Crohns Colitis; 2022 May; 16(4):606-615. PubMed ID: 34636839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the usefulness of imaging studies and biomarkers in the activity of Crohn's disease.
    Piotrowicz G; Klufczyńska A; Banaszkiewicz P; Dorosz Ł; Rydzewska G
    Prz Gastroenterol; 2021; 16(1):15-22. PubMed ID: 33986883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global Studies of Using Fecal Biomarkers in Predicting Relapse in Inflammatory Bowel Disease.
    Liu F; Lee SA; Riordan SM; Zhang L; Zhu L
    Front Med (Lausanne); 2020; 7():580803. PubMed ID: 33392214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical and clinical performance of the fully-automated LIAISONXL calprotectin immunoassay from DiaSorin in IBD patients.
    Vicente-Steijn R; Jansen JM; Bisheshar R; Haagen IA
    Pract Lab Med; 2020 Aug; 21():e00175. PubMed ID: 32637525
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.